NCT06066450View on ClinicalTrials.gov

Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 7, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Drug-eluting StentCoronary Artery Disease
Interventions
DEVICE

Genoss® DES system, Genoss® Osfit system

This is a drug-eluting stent used to improve the diameter of the coronary artery in patients with symptomatic ischemic heart disease, with de novo lesions in the native coronary artery, where the reference vessel diameter ranges from 2.25mm to 5.00mm.

Trial Locations (1)

16499

RECRUITING

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Genoss Co., Ltd.

INDUSTRY